Bayer Probiotic Claim Defense Argues FTC Wants Substantiation Standard That ‘Did Not Exist’
This article was originally published in The Tan Sheet
Executive Summary
DoJ says Bayer is avoiding answering requests for details on research that substantiates claims for Philip’s Colon Health and asks a judge to “resolve this matter.” Bayer says it has answered DoJ’s interrogatories, stating it could not comply with FTC’s alleged “standard because it did not exist until” the complaint was filed.
You may also be interested in...
Bayer Satisfies DoJ ‘Need To Know’ About Probiotic Claim Studies
A judge also grants Bayer’s request to depose an FTC attorney about the agency’s investigation that led to a contempt charge linked to allegedly violating a 2007 consent decree by making a drug claim for the Phillips’ Colon Health three-bacteria-strain formula.
Bayer Satisfies DoJ ‘Need To Know’ About Probiotic Claim Studies
A judge also grants Bayer’s request to depose an FTC attorney about the agency’s investigation that led to a contempt charge linked to allegedly violating a 2007 consent decree by making a drug claim for the Phillips’ Colon Health three-bacteria-strain formula.
FTC Supplement Settlements Spotlight Bayer, Mark First Hoodia Action
Bayer "went too far" with weight-loss and -control claims for its One-A-Day WeightSmart product and violated a 1991 sanction the product's previous owner agreed to, the Federal Trade Commission said Jan. 4 when it announced a record $3.2 million fine against the consumer healthcare giant